| 1 | Study | 1.23% | |
| 2 | Cancer | 0.82% | |
| 3 | Patients | 0.82% | |
| 4 | Awareness | 0.82% | |
| 5 | Therapy | 0.82% | |
| 6 | New | 0.82% | |
| 7 | Clinical | 0.82% | |
| 8 | Growth | 0.82% | |
| 9 | Report | 0.82% | |
| 10 | Case | 0.82% | |
| 11 | Blood | 0.82% | |
| 12 | Slow | 0.82% | |
| 13 | Young | 0.82% | |
| 14 | Trial | 0.82% | |
| 15 | Disease | 0.82% | |
| 16 | Endocrinopathy | 0.41% | |
| 17 | Bronchiolitis | 0.41% | |
| 18 | Meta-Analysis | 0.41% | |
| 19 | Glaucoma | 0.41% | |
| 20 | Drinks | 0.41% | |
| 21 | Saccharin | 0.41% | |
| 22 | Gut | 0.41% | |
| 23 | Parkinsons | 0.41% | |
| 24 | Tolerance | 0.41% | |
| 25 | Loss | 0.41% | |
| 26 | Tied | 0.41% | |
| 27 | Federal | 0.41% | |
| 28 | Hyponatremia | 0.41% | |
| 29 | Office | 0.41% | |
| 30 | Risk | 0.41% | |
| 31 | Vaccine | 0.41% | |
| 32 | Menopause | 0.41% | |
| 33 | Non-occlusive | 0.41% | |
| 34 | Evidence | 0.41% | |
| 35 | Antidepressant | 0.41% | |
| 36 | Spread | 0.41% | |
| 37 | Syndrome | 0.41% | |
| 38 | ADHD | 0.41% | |
| 39 | Drug | 0.41% | |
| 40 | Infection | 0.41% | |
| 41 | Nirsevimab | 0.41% | |
| 42 | Ischemia | 0.41% | |
| 43 | Expands | 0.41% | |
| 44 | Mesenteric | 0.41% | |
| 45 | Oral | 0.41% | |
| 46 | Randomized | 0.41% | |
| 47 | GII.17 | 0.41% | |
| 48 | Accelerated | 0.41% | |
| 49 | Detected | 0.41% | |
| 50 | Kashmir | 0.41% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||